BETAPRONE Drug Patent Profile
✉ Email this page to a colleague
When do Betaprone patents expire, and when can generic versions of Betaprone launch?
Betaprone is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in BETAPRONE is propiolactone. There is one drug master file entry for this compound. Additional details are available on the propiolactone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETAPRONE?
- What are the global sales for BETAPRONE?
- What is Average Wholesale Price for BETAPRONE?
Summary for BETAPRONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| DailyMed Link: | BETAPRONE at DailyMed |
US Patents and Regulatory Information for BETAPRONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | BETAPRONE | propiolactone | SOLUTION;IRRIGATION | 011657-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
